Terms: = Germ cell tumor AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
425 results:
1. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
2. Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
Postel MD; Darabi S; Howe JR; Liang WS; Craig DW; Demeure MJ
F1000Res; 2023; 12():417. PubMed ID: 37954063
[No Abstract] [Full Text] [Related]
3. SUZ12 inhibition attenuates cell proliferation of glioblastoma via post-translational regulation of cdkn1b.
Kim S; Jo S; Paek SH; Kang SS; Chung H
Genes Genomics; 2023 Dec; 45(12):1623-1632. PubMed ID: 37856053
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine tumors.
Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
[TBL] [Abstract] [Full Text] [Related]
5. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine tumors.
Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
[TBL] [Abstract] [Full Text] [Related]
6. Multiple endocrine neoplasia type 4 (men4): a thorough update on the latest and least known men syndrome.
Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
[TBL] [Abstract] [Full Text] [Related]
7. PRMT6-CDC20 facilitates glioblastoma progression via the degradation of cdkn1b.
Wang J; Xiao Z; Li P; Wu C; Li Y; Wang Q; Chen Y; Zhou H; Li Z; Wang Z; Lan Q; Wang Y
Oncogene; 2023 Mar; 42(14):1088-1100. PubMed ID: 36792756
[TBL] [Abstract] [Full Text] [Related]
8. MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.
Tong F; Zhao JX; Fang ZY; Cui XT; Su DY; Liu X; Zhou JH; Wang GX; Qiu ZJ; Liu SZ; Fu JQ; Kang CS; Wang JC; Wang QX
Pharmacol Res; 2023 Jan; 187():106606. PubMed ID: 36516884
[TBL] [Abstract] [Full Text] [Related]
9. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
10. [MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022].
Duval M; Haissaguerre M
Rev Med Interne; 2023 Jan; 44(1):12-18. PubMed ID: 36307322
[TBL] [Abstract] [Full Text] [Related]
11. germline cdkn1b variant type and site are associated with phenotype in men4.
Halperin R; Arnon L; Nasirov S; Friedensohn L; Gershinsky M; Telerman A; Friedman E; Bernstein-Molho R; Tirosh A
Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256846
[TBL] [Abstract] [Full Text] [Related]
12. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma.
Church C; Pulliam T; Longino N; Park SY; Smythe KS; Makarov V; Riaz N; Jing L; Amezquita R; Campbell JS; Gottardo R; Pierce RH; Choi J; Chan TA; Koelle DM; Nghiem P
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36252564
[TBL] [Abstract] [Full Text] [Related]
13. Survival times of patients with glioblastoma in low- and middle-income countries: a systematic review and meta-analysis.
Dy LF; Ong EP; Espiritu AI; Spears J; Omar AT
Neurosurg Rev; 2022 Oct; 45(5):3393-3403. PubMed ID: 36044130
[TBL] [Abstract] [Full Text] [Related]
14. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract] [Full Text] [Related]
15. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
Mäkinen N; Zhou M; Zhang Z; Kasai Y; Perez E; Kim GE; Thirlwell C; Nakakura E; Meyerson M
Genome Med; 2022 Aug; 14(1):82. PubMed ID: 35922826
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.
Gray A; Cui T; Bell EH; McElroy J; Sebastian E; Li F; Geurts M; Liu K; Robe P; Haque SJ; Chakravarti A
Exp Mol Pathol; 2022 Oct; 128():104813. PubMed ID: 35901926
[TBL] [Abstract] [Full Text] [Related]
17. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.
Global Retinoblastoma Study Group
Lancet Glob Health; 2022 Aug; 10(8):e1128-e1140. PubMed ID: 35839812
[TBL] [Abstract] [Full Text] [Related]
18. Activation of estrogen receptor ESR1 and ESR2 induces proliferation of the human testicular embryonal carcinoma NT2/D1 cells.
Macheroni C; Gameiro Lucas TF; Souza DS; Vicente CM; Pereira GJDS; Junior IDSV; Juliano MA; Porto CS
Mol Cell Endocrinol; 2022 Aug; 554():111708. PubMed ID: 35792284
[TBL] [Abstract] [Full Text] [Related]
19. Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma.
Liu YQ; Luo M; Shi Y; Guo Y; Zhang H; Yang KD; Li TR; Yang LQ; Liu TT; Huang B; Liu Q; He ZC; Zhang XN; Wang WY; Wang S; Zeng H; Niu Q; Zhang X; Cui YH; Zhang ZR; Bian XW; Ping YF
Oncogene; 2022 Jul; 41(30):3791-3803. PubMed ID: 35764885
[TBL] [Abstract] [Full Text] [Related]
20. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
Wang D; Jiang Y; Wang T; Wang Z; Zou F
BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
[TBL] [Abstract] [Full Text] [Related]
[Next]
